These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12945721)

  • 1. The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosus.
    Bates RL; Payne SJ; Drury SL; Nelson PN; Isenberg DA; Murphy JJ; Frampton G
    Lupus; 2003; 12(8):617-22. PubMed ID: 12945721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
    J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
    Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
    Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus.
    Chen M; Zhao MH; Zhang Y; Wang H
    Lupus; 2004; 13(8):584-9. PubMed ID: 15462487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen.
    Frampton G; Moriya S; Pearson JD; Isenberg DA; Ward FJ; Smith TA; Panayiotou A; Staines NA; Murphy JJ
    Rheumatology (Oxford); 2000 Oct; 39(10):1114-20. PubMed ID: 11035132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity against hNinein, a human centrosomal protein, in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Howng SL; Chou AK; Lin CC; Lin ZA; Wang CJ; Loh JK; Lieu AS; Yen JH; Lee CI; Hong YR
    Mol Med Rep; 2011; 4(5):825-30. PubMed ID: 21667027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel systemic lupus erythematosus autoantigens identified by human protein microarray technology.
    Huang W; Hu C; Zeng H; Li P; Guo L; Zeng X; Liu G; Zhang F; Li Y; Wu L
    Biochem Biophys Res Commun; 2012 Feb; 418(2):241-6. PubMed ID: 22266373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters.
    Bogaczewicz J; Sysa-Jedrzejowska A; Arkuszewska C; Zabek J; Kontny E; McCauliffe D; Wozniacka A
    Lupus; 2012 Apr; 21(5):477-84. PubMed ID: 22065093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
    J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus.
    Vázquez-Del Mercado M; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Oregon-Romero E; Navarro-Hernández RE; Salazar-Páramo M; Armendariz-Borunda J; Gámez-Nava JI; Gonzalez-Lopez L; Chan JY; Chan EK; Satoh M
    Arthritis Res Ther; 2010; 12(1):R6. PubMed ID: 20064217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of fibrinolytic parameters and plasminogen activator inhibitor 1 (PAI-1) promoter polymorphism on premature atherosclerosis in SLE patients.
    Bicakcigil M; Tasan D; Tasdelen N; Mutlu N; Yavuz S
    Lupus; 2011 Oct; 20(10):1063-71. PubMed ID: 21719525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
    Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
    Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and characterization of autoantibodies against modified self-proteins in SLE sera after exposure to reactive oxygen and nitrogen species.
    Ryan BJ; Eggleton P
    Methods Mol Biol; 2014; 1134():163-71. PubMed ID: 24497361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.